Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
17M
-
Shares change
-
+357K
-
Total reported value, excl. options
-
$136M
-
Value change
-
+$2.85M
-
Put/Call ratio
-
1.49
-
Number of buys
-
39
-
Number of sells
-
-33
-
Price
-
$7.97
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2020
104 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q4 2020.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17M shares
of 65.9M outstanding shares and own 25.86% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.76M shares), VANGUARD GROUP INC (2.22M shares), Redmile Group, LLC (2.05M shares), Skylands Capital, LLC (1.53M shares), Sectoral Asset Management Inc (1.1M shares), Neuberger Berman Group LLC (913K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (808K shares), Sargent Investment Group, LLC (674K shares), STATE STREET CORP (644K shares), and GEODE CAPITAL MANAGEMENT, LLC (568K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.